Processa Pharmaceuticals, Inc. Stock
Stocks
PCSA
US74275C4033
Biotechnology & Medical Research
OTC Markets Traded|
Market Closed -
Nasdaq
23:00:00 09/10/2026 +03
|
5-day change | 1st Jan Change | ||
| 1.520 USD | +12.59% |
|
-6.17% | -47.22% |
| Market Cap | 4.52M 4.04M 3.76M 3.42M 6.46M 438M 6.48M 45.25M 17.73M 223M 16.99M 16.62M 716M | P/E 2024 |
-0.23x | P/E 2025 | -0.28x |
|---|---|---|---|---|---|
| Enterprise Value | -1.01M -904K -841K -765K -1.44M -97.95M -1.45M -10.12M -3.97M -49.94M -3.8M -3.72M -160M | EV / Sales 2024 |
-
| EV / Sales 2025 | - |
| Free-Float |
85.18% | Yield 2024 * |
-
| Yield 2025 | - |
NasdaqUSD
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| PCSA | Delayed | |
CBOE
| PCSA | Real-time |
Last Transcript: Processa Pharmaceuticals, Inc.
| 1 day | +12.59% | ||
| 1 week | -6.17% | ||
| Current month | -7.32% | ||
| 1 month | -29.63% | ||
| 3 months | -19.58% | ||
| 6 months | -49.67% | ||
| Current year | -47.22% |
| 1 week | 1.04 | 1.87 | |
| 1 month | 1.04 | 2.12 | |
| Current year | 1.04 | 3.8 | |
| 1 year | 1.04 | 11.08 | |
| 3 years | 1.04 | 450 | |
| 5 years | 1.04 | 4,125 | |
| 10 years | 1.04 | 125,195.11 |
| Manager | Title | Age | Since |
|---|---|---|---|
George Ng
CEO | Chief Executive Officer | 52 | 08/08/2023 |
Patrick Lin
IRC | Investor Relations Contact | 60 | 29/03/2011 |
Wendy Guy
ADM | Chief Administrative Officer | 61 | 04/10/2017 |
| Director | Title | Age | Since |
|---|---|---|---|
David Young
CHM | Chairman | 73 | 29/03/2011 |
Justin Yorke
CHM | Chairman | 60 | 16/08/2022 |
Geraldine Pannu
BRD | Director/Board Member | 56 | 13/02/2020 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 8/8/26 A | Exercice | Chief Executive Officer | 3,200 | 0.1156% | ||
| 7/26/26 A | Other | Chief Financial Officer | 11,883 | 0.4293% | ||
| 7/26/26 A | Other | Chief Executive Officer | 9,384 | 0.3390% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +12.59% | -6.17% | -87.30% | -98.33% | 4.52M | ||
| -2.59% | -5.70% | +40.86% | +83.11% | 72.13B | ||
| +3.23% | -13.45% | +6.00% | +55.77% | 49.41B | ||
| +1.56% | +2.07% | +5.03% | +33.38% | 47.24B | ||
| +0.87% | -7.83% | +296.82% | +657.83% | 40.32B | ||
| +0.39% | -0.32% | +29.55% | +30.83% | 42.61B | ||
| +1.24% | -1.20% | +0.96% | +103.86% | 39.81B | ||
| -2.13% | -2.18% | +7.51% | +50.31% | 30.52B | ||
| +5.32% | +0.11% | -8.77% | -12.81% | 23.13B | ||
| +3.78% | +5.71% | +16.43% | -1.77% | 21.09B | ||
| Average | +2.40% | -5.18% | +30.71% | +90.22% | 36.63B | |
| Weighted average by Cap. | +0.74% | -4.28% | +46.74% | +118.77% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | - | - |
| Net income | -11.85M -10.58M -9.85M -8.96M -16.91M -1.15B -16.98M -118M -46.43M -585M -44.5M -43.53M -1.88B | -13.56M -12.11M -11.27M -10.25M -19.35M -1.31B -19.44M -136M -53.14M -669M -50.93M -49.82M -2.15B |
| Net Debt | -1.12M -998K -929K -845K -1.59M -108M -1.6M -11.18M -4.38M -55.16M -4.2M -4.11M -177M | -5.54M -4.95M -4.6M -4.18M -7.9M -536M -7.93M -55.37M -21.69M -273M -20.79M -20.34M -877M |
Employees
12
| Date | Price | Change | Volume |
|---|---|---|---|
| 09/10/26 | $1.520 | +12.59% | 2,947,199 |
| 08/10/26 | $1.350 | -4.93% | 12,803 |
| 07/10/26 | $1.420 | -6.58% | 12,904 |
| 06/10/26 | $1.520 | +2.01% | 18,585 |
| 05/10/26 | $1.490 | -7.45% | 25,737 |
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- PCSA Stock
Select your edition
All financial news and data tailored to specific country editions

















